Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study
Clinical trial NCT00439777 · COMPLETED
Trial details
- NCT number
- NCT00439777
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2011-09-01
- Enrollment
- 4833
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.